AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04480333 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Drugs: NA-831 (0.10 mg/kg) plus GS-5734 (1.00 mg/kg)
Description: The combined NA-831 and GS-5734 are in nanoparticle inhaled formulation
Study NCT04480333 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo 0.10 mg + 1.00 mg/kg
Description: The combined placebo are in nanoparticle inhaled formulation
Study NCT04480333 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Drugs: NA-831 (0.20 mg/kg) plus GS-5734 (2.00 mg/kg)
Description: The combined NA-831 and GS-5734 are in nanoparticle inhaled formulation
Study NCT04480333 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo 0.20 mg + 2.00 mg/kg
Description: Placebo 0.10 mg + 1.00 mg/kg
Study NCT02607280 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DS-5565
Description: DS-5565 15 mg (for moderate renal impairment) or 7.5 mg (for severe renal impairment), oral administration, Treatment period; 2-weeks titration and 12-weeks fixed dose
Study NCT03729323 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational interviewing
Description: In Diabetes and hypertension, nursing consultations to support the care should be focused on their educational component the orientation of measures that prove to reduce blood pressure, improve the glycemic indices, the lipid profile and the Cardiovascular risk classification, among them: adherence to drug therapy, proper diet, body weight maintenance, stimulating active life and regular physical exercise, reducing alcoholic beverage consumption, reducing stress and abandoning Smoking. In this group, these care will be addressed based on the principles and techniques of the Motivational Interviewing.
Study NCT03729323 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Nursing Consultation
Description: In Diabetes and hypertension, nursing consultations to support the care should be focused on their educational component the orientation of measures that prove to reduce blood pressure, improve the glycemic indices, the lipid profile and the Cardiovascular risk classification, among them: adherence to drug therapy, proper diet, body weight maintenance, stimulating active life and regular physical exercise, reducing alcoholic beverage consumption, reducing stress and abandoning Smoking. In this group, these care will be approached in a conventional manner, as routine of the services, based on the recommendations of the Primary Care Strategy Notebooks for the care of chronic conditions in DM2 and SAH and the SSC-GHC Institutional Protocol for SAH and DM2 Patient Care.
Study NCT03203174 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Microneedle
Description: Microneedles are small needles used to create holes in the stratum corneum (top layer of skin) with relatively low amount of pain.
Study NCT03203174 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Microneedle
Description: Flat roller with no needles on the roller
Study NCT03203174 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Botulinum Toxin Type A
Description: Botulinum toxin type A will be applied to the palm
Study NCT03203174 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Botulinum Toxin Type A
Description: Botulinum toxin type A will be applied to the palm
Study NCT03203174 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Saline
Description: Saline applied to the palm
Study NCT03203174 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Saline
Description: Saline applied to the palm
Study NCT02272153 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Egg refined grain
Study NCT02272153 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Egg Whole Grain
Study NCT02272153 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cereal Refined grain
Study NCT00878319 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Open reduction and internal fixation (ORIF)
Description: Antero-latero or posterior surgical approach using dynamic compression plate
Study NCT00878319 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Non-surgical
Description: Sugartong splint followed by transition to functional co-aptation brace
Study NCT04271566 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Education program
Description: A mobile application plus short message service (SMS) program to deliver disease-related health education and reinforcement to experimental group patients and see its impact on their health related quality of life, physical activity and Body mass index
Study NCT02882841 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Biopsies, stool and blood collection
Study NCT02774564 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIA 3-202
Description: Nebicapone tablets 50 mg, oral administration
Study NCT02774564 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Nebicapone matching placebo tablets
Study NCT02774564 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Nebicapone matching placebo tablets
Study NCT02774564 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sinemet®
Description: Sinemet® CR 200/50 (levodopa 200 mg / carbidopa 50 mg) tablets
Study NCT02774564 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Sinemet®
Description: Sinemet® CR 200/50 (levodopa 200 mg / carbidopa 50 mg) tablets
Study NCT04717947 — intervention group
Intervention type: PROCEDURE
Intervention: Interval between NAT and surgery
Description: Evaluate three groups according to the interval between the end of neoadjuvant therapy and surgery.
Study NCT01618578 — intervention group
Intervention type: PROCEDURE
Intervention: rubber hand illusion
Description: There were three consecutive trials of the RHI:~1. one control trial: asynchronous condition (3 Min.)~2. two experimental trials (conducted on both hands):synchronous condition (3 Min.),additionally watching the prosthesis being threatened (20 sec.)
Study NCT02128698 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Protein
Description: Postoperative intake of 25 g per day starting on the first day after hospital discharge until 6 months postoperatively.
Study NCT02128698 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Protein
Description: Postoperative intake of 25 g per day starting on the first day after hospital discharge until 6 months postoperatively.
Study NCT02128698 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Postoperative intake of 25 g per day starting on the first day after hospital discharge until 6 months postoperatively.
Study NCT02128698 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Postoperative intake of 25 g per day starting on the first day after hospital discharge until 6 months postoperatively.
Study NCT02128698 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Computer-assisted exercise
Description: Postoperative regular computer-assisted exercise using Nintendo Wii Mini, Nintendo Wii Balance Board and Wii Fit Plus Software. Exercise is advised to be done 4 times per week.
Study NCT02128698 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Computer-assisted exercise
Description: Postoperative regular computer-assisted exercise using Nintendo Wii Mini, Nintendo Wii Balance Board and Wii Fit Plus Software. Exercise is advised to be done 4 times per week.
Study NCT02128698 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual exercise
Description: Postoperative regular exercise using written exercise instructions. Exercise is advised to be done 4 times per week.
Study NCT02638233 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Sofosbuvir 400mg / Ledipasvir 90 mg (FDC)
Study NCT02918292 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antithymocyte Globulin (ATG)
Description: Administration of ATG will be 0.5 mg/kg IV on Day -9 over 6 hours and 2 mg/kg IV on Days -8 and -7 over 4 hours.
Study NCT02918292 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Fludarabine dose will be 30 mg/m\^2 IV daily for 5 days from Day -6 to Day -2.
Study NCT02918292 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Cyclophosphamide dose will be 14.5 mg/kg IV daily for 2 days (Day -6 to Day -5) prior to transplantation and 50 mg/kg IV daily for 2 days (Day +3 to Day +4) after transplantation.
Study NCT02918292 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Total Body Irradiation (TBI)
Description: TBI is to be delivered in a single dose of 200 cGy on Day -1.
Study NCT02918292 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Haplo HSCT
Description: Eligible patients without a fully matched related or unrelated donor available will undergo haploidentical bone marrow transplant.
Study NCT02918292 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tacrolimus
Description: Tacrolimus should be started on Day +5 and administered to maintain a level of 10-15 ng/mL.
Study NCT02918292 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Description: MMF dose will be 15 mg/kg PO three times a day (TID) up to 1 gm TID (or IV equivalent) starting on Day +5.
Study NCT02918292 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G-CSF
Description: G-CSF will be given IV or SQ starting on Day +5 at 5 mcg/kg/day until ANC is > 1500 for 3 days.
Study NCT02826577 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pregnenolone 175mg
Description: Single Dose 175mg
Study NCT02826577 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pregnenolone 400mg
Description: Single Dose 400mg
Study NCT02826577 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Single Dose
Study NCT01273714 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: thyroid resection
Description: bilateral subtotal versus total thyroidectomy
Study NCT01273714 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: thyroid resection
Description: bilateral subtotal versus total thyroidectomy
Study NCT04609709 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Thrust Manipulation, Electric Dry Needling and Exercise
Description: Thrust Manipulation, Electric Dry Needling
Study NCT04609709 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Non-thrust Mobilization, Soft-Tissue Mobilization, Exercise and TENS
Description: Non-thrust Mobilization, Soft-Tissue Mobilization, Exercise and TENS
Study NCT03539185 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Videolaryngoscope Airtraq
Description: Awake orotracheal intubation with laryngeal nerve block and remifentanil sedation
Study NCT03539185 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Fiberoptic bronchoscope
Description: Awake nasotracheal intubation with laryngeal nerve block and remifentanil sedation
Study NCT01438372 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose
Description: Intravenous iron sucrose will be administered on days 1, 7, 14, and 21 using the formula: Total dose: (normal Hb for age - initial Hb)/100 x blood volume (ml) x 3.4 x 1.5. First dose will be infused over 30 minutes, with subsequent doses administered over 15 minutes if no reactions encountered.
Study NCT01438372 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oral ferrous sulfate
Description: Oral ferrous sulfate will be administered at 3 mg/kg/day divided into 2 doses for 28 days. A tablet form of ferrous sulfate (325 mg with 65 mg of elemental iron per tablet) will be used.
Study NCT01173419 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: VNUS RF ClosureFAST
Description: VNUS® RF ClosureFAST is a minimally invasive varicose vein treatment procedure that uses radiofrequency energy (electricity) to heat, collapse and seal off the targeted blood vessels.
Study NCT01173419 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: VenaCure EVLT NeverTouch
Description: Endovenous Laser Treatment (EVLT) uses laser energy, which is a highly concentrated beam of light to treat varicose veins.
Study NCT04146623 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CodaVax-H1N1 influenza vaccine
Description: CodaVax-H1N1, a live attenuated vaccine (LAIV) strain based on the A/California/07/2009 (H1N1) influenza virus, administered once intranasally via a sprayer at a dose of 8 x10\^5 plaque forming units (PFU).
Study NCT04146623 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Normal Saline Placebo
Description: Saline (0.9%) administered intranasally via sprayer
Study NCT02561663 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: NWT-03, an egg-white protein hydrolysate
Description: egg-white protein hydrolysate
Study NCT02561663 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Study NCT02003261 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Unified Protocol with Treatment As Usual
Description: Unified Protocol(UP) is a transdiagnostic cognitive-behavioral therapy for depressive and anxiety disorders, which is developed by Dr. Barlow and his colleagues at Boston university.~UP is weekly, face to face, individual psychotherapy consisting of 9 to 20 sessions. Average session number is 16 sessions. Contents of the treatment includes motivational enhancement, psychoeducation of treatment rationale and emotion, emotion awareness training, cognitive reappraisal, avoidance and emotion driven behaviors, interoceptive exposure and emotion exposure.
Study NCT02003261 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Treatment As Usual
Description: Most of the TAU will be drug therapy or nonsystematic supportive psychotherapy.
Study NCT02003261 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Treatment As Usual
Description: Most of the TAU will be drug therapy or nonsystematic supportive psychotherapy.
Study NCT02766452 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: You and your child in the recovery room DVD
Study NCT02766452 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard pre-operative preparation
Description: Attendance to the Pre-anesthetic assessment clinic to meet with registered practical nurse and anesthesiologist (physical assessment and medical history). Completion of the Surgery Virtual Tour.
Study NCT02766452 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Standard pre-operative preparation
Description: Attendance to the Pre-anesthetic assessment clinic to meet with registered practical nurse and anesthesiologist (physical assessment and medical history). Completion of the Surgery Virtual Tour.
Study NCT03790618 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 3,4-Methylenedioxymethamphetamine
Description: Participants will be given 0.75mg/kg of 1.5mg/kg MDMA
Study NCT03790618 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 3,4-Methylenedioxymethamphetamine
Description: Participants will be given 0.75mg/kg of 1.5mg/kg MDMA
Study NCT03790618 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: methamphetamine
Description: Please see above.
Study NCT03790618 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: methamphetamine
Description: Please see above.
Study NCT03786185 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MusicPlast
Description: Each subject will receive 20 sessions of the computerized training based on a simplified music reading protocol. The training will be provided via a smartphone or a tablet. Each training session will last for 20 minutes and the log file will be directly available to the researcher, allowing him/her to follow subject's timely participation. The stimuli used in the training protocol will consist of a visual image showing a circle on top of a background of 5 horizontal lines. The auditory part of the stimulus will consist of piano melodies of known songs. The position of the circle within the five lines will either follow the rule the higher the pitch of the tone, the higher the position of the circle or it will violate the above rule. The task requires audiovisual integration.
Study NCT03786185 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: MusicPlast
Description: Each subject will receive 20 sessions of the computerized training based on a simplified music reading protocol. The training will be provided via a smartphone or a tablet. Each training session will last for 20 minutes and the log file will be directly available to the researcher, allowing him/her to follow subject's timely participation. The stimuli used in the training protocol will consist of a visual image showing a circle on top of a background of 5 horizontal lines. The auditory part of the stimulus will consist of piano melodies of known songs. The position of the circle within the five lines will either follow the rule the higher the pitch of the tone, the higher the position of the circle or it will violate the above rule. The task requires audiovisual integration.
Study NCT03786185 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: MusicPlast Control
Description: Each subject will receive 20 sessions of the computerized training within a period of 4 weeks, aiming to train visual search via spot-the-difference tasks and identification of dissonance in music. Auditory and visual stimuli are concurrently presented, but do not require audiovisual integration.
Study NCT01713894 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Decision Aid
Study NCT01713894 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard
Study NCT00481767 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Cervarix
Description: The vaccine was administered according to a 0, 1, and 6-month schedule, intramuscularly into the deltoid region of the non-dominant arm.
Study NCT00481767 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Al(OH)3
Description: Placebo was administered according to a 0, 1 and 6-month schedule, intramuscularly into the deltoid region of the non-dominant arm.
Study NCT00840593 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Non-surgical group
Description: The non-surgical treatment consisted of immobilisation of the injured AC-joint in a Kenny-Howard-type splint for four weeks. The patient was encouraged in mobilisation of the elbow several times per day and the mobilisation of the shoulder with pendulum type movements were initiated four weeks after the injury. Active mobilisation of the shoulder was allowed six weeks after the injury.
Study NCT00840593 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgical group
Description: The surgical treatment was accomplished within two days after the injury, and it consisted of an open reduction and fixation of the AC joint with two smooth Kirschner wires (2 mm in diameter) across the AC-joint. The K-wires were bent at the proximal ends, with suturing of the superior AC ligament. The position of Kirschner wires was confirmed during the operation using C-arm transillumination. The articular disc of AC joint was removed if it was damaged. Postoperative care consisted of immobilisation of the AC joint in a sling, (Polysling, body band) for four weeks and the mobilisation of the shoulder started four to six weeks later in a similar manner as in the non-operative group.
Study NCT04012424 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: curcumin group:Curcumin is an ancient coloring spice . Interestingly, it has various pharmacological activities including analgesic, anti-inf
Description: effect of taking 400mg curcumin one hour before endodontic ttt on post endodontic pain immediatelly and after 8,12,24,48 hours after endodontic treatment.Curcumin is an ancient coloring spice of Asia which is powerful antioxidant , it has hepatoprotective effect and traditionally used for many remedies . Interestingly, it has various pharmacological activities including analgesic, anti-inflammatory , It is even reported to have antimicrobial effect .~Medical clinical trials reported on the analgesic effect of curcuminoids in reducing postsurgical pain osteoarthritis and rheumatoid arthritis .~other name : curcum, tumeric
Study NCT04012424 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: curcumin group:Curcumin is an ancient coloring spice . Interestingly, it has various pharmacological activities including analgesic, anti-inf
Description: effect of taking 400mg curcumin one hour before endodontic ttt on post endodontic pain immediatelly and after 8,12,24,48 hours after endodontic treatment.Curcumin is an ancient coloring spice of Asia which is powerful antioxidant , it has hepatoprotective effect and traditionally used for many remedies . Interestingly, it has various pharmacological activities including analgesic, anti-inflammatory , It is even reported to have antimicrobial effect .~Medical clinical trials reported on the analgesic effect of curcuminoids in reducing postsurgical pain osteoarthritis and rheumatoid arthritis .~other name : curcum, tumeric
Study NCT04012424 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 400mg starch
Description: patints taking(400mg) starch in tabelts in same shape and color of control group before endodontic treatment by one hour and post endodontic pain immediately and after 8,12,24,48 hours after treatment completion